New technologies for delineating and characterizing the lipid exome: Prospects for understanding familial combined hyperlipidemia

Journal of Lipid Research

Volumn 50, Issue SUPPL., 2009, Pages

  Horswell, Stuart D ^a   Ringham, Helen E ^a   Shoulders, Carol C ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Genetic heterogeneity; Linkage

Indexed keywords

LIPID;

ANIMAL; COMPUTER SIMULATION; EXON; FAMILIAL HYPERLIPEMIA; GENETICS; HUMAN; MEDICAL TECHNOLOGY; METHODOLOGY; REVIEW;

ANIMALS; COMPUTER SIMULATION; EXONS; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; LIPIDS; TECHNOLOGY, MEDICAL;

EID: 66349102249     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R800081-JLR200     Document Type: Review

References (50)

1. Evans, K., G. C. Burdge, S. A. Wootton, J. M. Collins, M. L. Clark, G. D. Tan, F. Karpe, and K. N. Frayn. 2008. Tissue-specific stable isotope measurements of postprandial lipid metabolism in familial combined hyperlipidaemia. Atherosclerosis. 197: 164-170. (Pubitemid 351273236)
2. Hussain, M. M., P. Rava, X. Pan, K. Dai, S. K. Dougan, J. Iqbal, F. Lazare, and I. Khatun. 2008. Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism. Curr. Opin. Lipidol. 19: 277-284. (Pubitemid 351653566)
3. ter Avest, E., A. D. Sniderman, S. J. Bredie, A. Wiegman, A. F. Stalenhoef, and J. de Graaf. 2007. Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia. Clin. Sci. (Lond.). 112: 131-139. (Pubitemid 46120092)
4. Thomas, E. L., E. Potter, I. Tosi, J. Fitzpatrick, G. Hamilton, V. Amber, R. Hughes, C. North, P. Holvoet, M. Seed, et al. 2007. Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: relation to liver, muscle and regional body fat content. Atherosclerosis. 195: e181-e190. (Pubitemid 47561966)
5. Kahvejian, A., J. Quackenbush, and J. F. Thompson. 2008. What would you do if you could sequence everything? Nat. Biotechnol. 26: 1125-1133.
6. Rothberg, J. M., and J. H. Leamon. 2008. The development and impact of 454 sequencing. Nat. Biotechnol. 26: 1117-1124.
7. Shendure, J., and H. Ji. 2008. Next-generation DNA sequencing. Nat. Biotechnol. 26: 1135-1145.
8. Wheeler, D. A., M. Srinivasan, M. Egholm, Y. Shen, L. Chen, A. McGuire, W. He, Y. J. Chen, V. Makhijani, G. T. Roth, et al. 2008. The complete genome of an individual by massively parallel DNA sequencing. Nature. 452: 872-876. (Pubitemid 351550870)
9. Bier, F. F., M. von Nickisch-Rosenegk, E. Ehrentreich-Forster, E. Reiss, J. Henkel, R. Strehlow, and D. Andresen. 2008. DNA microarrays. Adv. Biochem. Eng. Biotechnol. 109: 433-453. (Pubitemid 350202996)
10. Steemers, F. J., and K. L. Gunderson. 2007. Whole genome genotyping technologies on the BeadArray platform. Biotechnol. J. 2: 41-49. (Pubitemid 46738887)
11. Voisey, J., and C. P. Morris. 2008. SNP technologies for drug discovery: a current review. Curr. Drug Discov. Technol. 5: 230-235.
12. Hopkins, P. N., G. Heiss, R. C. Ellison, M. A. Province, J. S. Pankow, J. H. Eckfeldt, and S. C. Hunt. 2003. Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study. Circulation. 108: 519-523. (Pubitemid 36961163)
13. Pitsavos, C., I. Skoumas, C. Masoura, K. Aznaouridis, L. Papadimitriou, C. Chrysohoou, N. Giotsas, M. Toutouza, and C. Stefanadis. 2008. Prevalence and determinants of coronary artery disease in males and females with familial combined hyperlipidaemia. Atherosclerosis. 199: 402-407.
14. Gaddi, A., A. F. Cicero, F. O. Odoo, A. A. Poli, and R. Paoletti. 2007. Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date. Vasc. Health Risk Manag. 3: 877-886.
15. Shoulders, C. C., E. L. Jones, and R. P. Naoumova. 2004. Genetics of familial combined hyperlipidemia and risk of coronary heart disease. Hum Mol Genet 13 Spec No 1: R149-160. (Pubitemid 38443809)
16. Thomas, R. J. 2004. Can familial combined hyperlipidemia diagnostic criteria be improved by the use of a nomogram? Nat. Clin. Pract. Cardiovasc. Med. 1: 78-79. (Pubitemid 40823701)
17. Wierzbicki, A. S., C. A. Graham, I. S. Young, and D. P. Nicholls. 2008. Familial combined hyperlipidaemia: under - defined and under - diagnosed? Curr. Vasc. Pharmacol. 6: 13-22.
18. Jha, K. N., I. A. Shumilin, L. C. Digilio, O. Chertihin, H. Zheng, G. Schmitz, P. E. Visconti, C. J. Flickinger, W. Minor, and J. C. Herr. 2008. Biochemical and structural characterization of apolipoprotein A-I binding protein, a novel phosphoprotein with a potential role in sperm capacitation. Endocrinology. 149: 2108-2120. (Pubitemid 351574530)
19. Willnow, T. E., A. Hammes, and S. Eaton. 2007. Lipoproteins and their receptors in embryonic development: more than cholesterol clearance. Development. 134: 3239-3249. (Pubitemid 350018425)
20. Woollett, L. A. 2008. Where does fetal and embryonic cholesterol originate and what does it do? Annu. Rev. Nutr. 28: 97-114.
21. Viccica, G., E. Vignali, and C. Marcocci. 2007. Role of the cholesterol biosynthetic pathway in osteoblastic differentiation. J. Endocrinol. Invest. 30: 8-12.
22. Bensinger, S. J., and P. Tontonoz. 2008. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature. 454: 470-477.
23. Voet, D., and J. G. Voet. 2004. Biochemistry. 3rd ed. John Wiley & Sons, New York. 183-185.
24. Eichenbaum-Voline, S., M. Olivier, E. L. Jones, R. P. Naoumova, B. Jones, B. Gau, H. N. Patel, M. Seed, D. J. Betteridge, D. J. Galton, et al. 2004. Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 24: 167-174. (Pubitemid 38082429)
25. Lee, J. C., D. Weissglas-Volkov, M. Kyttala, J. S. Sinsheimer, A. Jokiaho, T. W. de Bruin, A. J. Lusis, M. L. Brennan, M. M. van Greevenbroek, C. J. van der Kallen, et al. 2007. USF1 contributes to high serum lipid levels in Dutch FCHL families and US whites with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 27: 2222-2227. (Pubitemid 350287253)
26. Marcil, M., H. Vu, W. Cui, Z. Dastani, J. C. Engert, D. Gaudet, M. Castro-Cabezas, A. D. Sniderman, J. Genest, Jr., and K. Cianflone. 2006. Identification of a novel C5L2 variant (S323I) in a French Canadian family with familial combined hyperlipemia. Arterioscler. Thromb. Vasc. Biol. 26: 1619-1625. (Pubitemid 44288992)
27. Ng, P. C., S. Levy, J. Huang, T. B. Stockwell, B. P. Walenz, K. Li, N. Axelrod, D. A. Busam, R. L. Strausberg, and J. C. Venter. 2008. Genetic variation in an individual human exome. PLoS Genet. 4: e1000160.
28. Kryukov, G. V., L. A. Pennacchio, and S. R. Sunyaev. 2007. Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. Am. J. Hum. Genet. 80: 727-739. (Pubitemid 46564409)
29. Ahituv, N., N. Kavaslar, W. Schackwitz, A. Ustaszewska, J. Martin, S. Hebert, H. Doelle, B. Ersoy, G. Kryukov, S. Schmidt, et al. 2007. Medical sequencing at the extremes of human body mass. Am. J. Hum. Genet. 80: 779-791. (Pubitemid 46564414)
30. Wang, J., H. Cao, M. R. Ban, B. A. Kennedy, S. Zhu, S. Anand, S. Yusuf, R. L. Pollex, and R. A. Hegele. 2007. Resequencing genomic DNA of patients with severe hypertriglyceridemia (MIM 144650). Arterioscler. Thromb. Vasc. Biol. 27: 2450-2455. (Pubitemid 350203963)
31. Cohen, J. C., R. S. Kiss, A. Pertsemlidis, Y. L. Marcel, R. McPherson, and H. H. Hobbs. 2004. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science. 305: 869-872. (Pubitemid 39038422)
32. Civeira, F., E. Jarauta, A. Cenarro, A. L. Garcia-Otin, D. Tejedor, D. Zambon, M. Mallen, E. Ros, and M. Pocovi. 2008. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting. J. Am. Coll. Cardiol. 52: 1546-1553.
33. Tai, E. S., and J. M. Ordovas. 2008. Clinical significance of apolipoprotein A5. Curr. Opin. Lipidol. 19: 349-354.
34. Kluger, M., J. Heeren, and M. Merkel. Apoprotein A-V: an important regulator of triglyceride metabolism. J. Inherit. Metab. Dis. Epub ahead of print. April 14, 2008.
35. Wong, K., and R. O. Ryan. 2007. Characterization of apolipoprotein A-V structure and mode of plasma triacylglycerol regulation. Curr. Opin. Lipidol. 18: 319-324. (Pubitemid 46743057)
36. Nohara, A., M. A. Kawashiri, T. Claudel, M. Mizuno, M. Tsuchida, M. Takata, S. Katsuda, K. Miwa, A. Inazu, F. Kuipers, et al. 2007. High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia. Arterioscler. Thromb. Vasc. Biol. 27: 923-928. (Pubitemid 46606726)
37. Boekholdt, S. M., R. J. Peters, K. Fountoulaki, J. J. Kastelein, and E. J. Sijbrands. 2003. Molecular variation at the apolipoprotein B gene locus in relation to lipids and cardiovascular disease: a systematic meta-analysis. Hum. Genet. 113: 417-425. (Pubitemid 37254246)
38. Wung, S. F., M. V. Kulkarni, C. R. Pullinger, M. J. Malloy, J. P. Kane, and B. E. Aouizerat. 2006. The lipoprotein lipase gene in combined hyperlipidemia: evidence of a protective allele depletion. Lipids Health Dis. 5: 19.
39. Abifadel, M., L. Bernier, G. Dubuc, G. Nuel, J. P. Rabes, J. Bonneau, A. Marques, M. Marduel, M. Devillers, D. Erlich, et al. 2008. A PCSK9 variant and familial combined hyperlipidemia. J Med Genet. 45: 780-786.
40. Chen, S. N., C. M. Ballantyne, A. M. Gotto, Jr., Y. Tan, J. T. Willerson, and A. J. Marian. 2005. A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis. J. Am. Coll. Cardiol. 45: 1611-1619. (Pubitemid 40704495)
41. Barnes, C., V. Plagnol, T. Fitzgerald, R. Redon, J. Marchini, D. Clayton, and M. E. Hurles. 2008. A robust statistical method for case-control association testing with copy number variation. Nat. Genet. 40: 1245-1252.
42. Korn, J. M., F. G. Kuruvilla, S. A. McCarroll, A. Wysoker, J. Nemesh, S. Cawley, E. Hubbell, J. Veitch, P. J. Collins, K. Darvishi, et al. 2008. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat. Genet. 40: 1253-1260.
43. McCarroll, S. A. 2008. Extending genome-wide association studies to copy-number variation. Hum. Mol. Genet. 17: R135-R142.
44. Wang, K., Z. Chen, M. G. Tadesse, J. Glessner, S. F. Grant, H. Hakonarson, M. Bucan, and M. Li. 2008. Modeling genetic inheritance of copy number variations. Nucleic Acids Res. 36: e138.
45. Sebat, J., B. Lakshmi, D. Malhotra, J. Troge, C. Lese-Martin, T. Walsh, B. Yamrom, S. Yoon, A. Krasnitz, J. Kendall, et al. 2007. Strong association of de novo copy number mutations with autism. Science. 316: 445-449. (Pubitemid 46651493)
46. Walsh, T., J. M. McClellan, S. E. McCarthy, A. M. Addington, S. B. Pierce, G. M. Cooper, A. S. Nord, M. Kusenda, D. Malhotra, A. Bhandari, et al. 2008. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science. 320: 539-543. (Pubitemid 351590668)
47. Hollox, E. J., U. Huffmeier, P. L. Zeeuwen, R. Palla, J. Lascorz, D. Rodijk-Olthuis, P. C. van de Kerkhof, H. Traupe, G. de Jongh, M. den Heijer, et al. 2008. Psoriasis is associated with increased beta-defensin genomic copy number. Nat. Genet. 40: 23-25.
48. Pollex, R. L., and R. A. Hegele. 2005. Complex trait locus linkage mapping in atherosclerosis: time to take a step back before moving forward? Arterioscler. Thromb. Vasc. Biol. 25: 1541-1544. (Pubitemid 41098919)
49. Lee, J. C., D. Weissglas-Volkov, M. Kyttala, Z. Dastani, R. M. Cantor, E. M. Sobel, C. L. Plaisier, J. C. Engert, M. M. van Greevenbroek, J. P. Kane, et al. 2008. WW-domain-containing oxidoreductase is associated with low plasma HDL-C levels. Am. J. Hum. Genet. 83: 180-192.
50. Lander, E., and L. Kruglyak. 1995. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat. Genet. 11: 241-247.